APO Research
Talk to an analyst

APO RESEARCH · REPORT

Efavirenz Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Efavirenz Tablets Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchEfavirenz Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Efavirenz Tablets Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Efavirenz Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Efavirenz Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Efavirenz Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Efavirenz Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Efavirenz Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Efavirenz Tablets market include Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, Huahai Pharmaceutical and DESANO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Efavirenz Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Efavirenz Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Efavirenz Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Efavirenz Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Efavirenz Tablets Segment by Company

Aurobindo Pharma

Cipla

Hetero

Strides Pharma

Anhui Biochem Bio-Pharmaceutical

Huahai Pharmaceutical

DESANO

Efavirenz Tablets Segment by Type

200mg

50mg

600mg

Efavirenz Tablets Segment by Application

Adult

Child

Efavirenz Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Efavirenz Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Efavirenz Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Efavirenz Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Efavirenz Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Efavirenz Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Efavirenz Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Efavirenz Tablets industry.

Chapter 3: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Efavirenz Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Efavirenz Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Efavirenz Tablets Industry Trends Table 2. Efavirenz Tablets Industry Drivers Table 3. Efavirenz Tablets Industry Opportunities and Challenges Table 4. Efavirenz Tablets Industry Restraints Table 5. Global Efavirenz Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Efavirenz Tablets Revenue Share by Company (2021-2026) Table 7. Global Efavirenz Tablets Sales Volume by Company (k units) & (2021-2026) Table 8. Global Efavirenz Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Efavirenz Tablets Average Price (USD/unit) of Company (2021-2026) Table 10. Global Efavirenz Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Efavirenz Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Efavirenz Tablets Company, Product Type & Application Table 13. Global Efavirenz Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Efavirenz Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 200mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of 600mg Table 20. Global Efavirenz Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Efavirenz Tablets Sales Volume by Type (2021-2026) & (k units) Table 22. Global Efavirenz Tablets Sales Volume by Type (2027-2032) & (k units) Table 23. Global Efavirenz Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Efavirenz Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Efavirenz Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Efavirenz Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Efavirenz Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Efavirenz Tablets Sales Value Share by Type (2021-2026) Table 29. Global Efavirenz Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adult Table 31. Significant Companies of Child Table 32. Global Efavirenz Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Efavirenz Tablets Sales Volume by Application (2021-2026) & (k units) Table 34. Global Efavirenz Tablets Sales Volume by Application (2027-2032) & (k units) Table 35. Global Efavirenz Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Efavirenz Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Efavirenz Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Efavirenz Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Efavirenz Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Efavirenz Tablets Sales Value Share by Application (2021-2026) Table 41. Global Efavirenz Tablets Sales Value Share by Application (2027-2032) Table 42. Global Efavirenz Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Efavirenz Tablets Sales by Region (2021-2026) & (k units) Table 44. Global Efavirenz Tablets Sales Market Share by Region (2021-2026) Table 45. Global Efavirenz Tablets Sales by Region (2027-2032) & (k units) Table 46. Global Efavirenz Tablets Sales Market Share by Region (2027-2032) Table 47. Global Efavirenz Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Efavirenz Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Efavirenz Tablets Sales Value Share by Region (2021-2026) Table 50. Global Efavirenz Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Efavirenz Tablets Sales Value Share by Region (2027-2032) Table 52. Global Efavirenz Tablets Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Efavirenz Tablets Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Efavirenz Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 57. Global Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 58. Global Efavirenz Tablets Sales by Country (2027-2032) & (k units) Table 59. Global Efavirenz Tablets Sales Market Share by Country (2027-2032) Table 60. Global Efavirenz Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Efavirenz Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Efavirenz Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Efavirenz Tablets Sales Value Market Share by Country (2027-2032) Table 64. Aurobindo Pharma Company Information Table 65. Aurobindo Pharma Business Overview Table 66. Aurobindo Pharma Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Aurobindo Pharma Efavirenz Tablets Product Portfolio Table 68. Aurobindo Pharma Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Cipla Efavirenz Tablets Product Portfolio Table 73. Cipla Recent Development Table 74. Hetero Company Information Table 75. Hetero Business Overview Table 76. Hetero Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Hetero Efavirenz Tablets Product Portfolio Table 78. Hetero Recent Development Table 79. Strides Pharma Company Information Table 80. Strides Pharma Business Overview Table 81. Strides Pharma Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Strides Pharma Efavirenz Tablets Product Portfolio Table 83. Strides Pharma Recent Development Table 84. Anhui Biochem Bio-Pharmaceutical Company Information Table 85. Anhui Biochem Bio-Pharmaceutical Business Overview Table 86. Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio Table 88. Anhui Biochem Bio-Pharmaceutical Recent Development Table 89. Huahai Pharmaceutical Company Information Table 90. Huahai Pharmaceutical Business Overview Table 91. Huahai Pharmaceutical Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Huahai Pharmaceutical Efavirenz Tablets Product Portfolio Table 93. Huahai Pharmaceutical Recent Development Table 94. DESANO Company Information Table 95. DESANO Business Overview Table 96. DESANO Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. DESANO Efavirenz Tablets Product Portfolio Table 98. DESANO Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Efavirenz Tablets Distributors List Table 102. Efavirenz Tablets Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Efavirenz Tablets Product Image Figure 2. Global Efavirenz Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Efavirenz Tablets Sales (2021-2032) & (k units) Figure 5. Global Efavirenz Tablets Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Efavirenz Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 200mg Image Figure 10. 50mg Image Figure 11. 600mg Image Figure 12. Global Efavirenz Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Efavirenz Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Efavirenz Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Efavirenz Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Efavirenz Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Efavirenz Tablets Sales Value Share by Type (2021-2032) Figure 18. Adult Image Figure 19. Child Image Figure 20. Global Efavirenz Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Efavirenz Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Efavirenz Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Efavirenz Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Efavirenz Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Efavirenz Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Efavirenz Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Efavirenz Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Efavirenz Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Efavirenz Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Efavirenz Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Efavirenz Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Efavirenz Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Efavirenz Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Efavirenz Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Efavirenz Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Efavirenz Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Efavirenz Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Efavirenz Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 50mg
  • 600mg
Applications
  • Adult
  • Child
Companies covered
  • Aurobindo Pharma
  • Cipla
  • Hetero
  • Strides Pharma
  • Anhui Biochem Bio-Pharmaceutical
  • Huahai Pharmaceutical
  • DESANO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Efavirenz Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Efavirenz Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Efavirenz Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Efavirenz Tablets Market Dynamics
  1. 2.1 Efavirenz Tablets Industry Trends
  2. 2.2 Efavirenz Tablets Industry Drivers
  3. 2.3 Efavirenz Tablets Industry Opportunities and Challenges
  4. 2.4 Efavirenz Tablets Industry Restraints
3 Efavirenz Tablets Market by Company
  1. 3.1 Global Efavirenz Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Efavirenz Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Efavirenz Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Efavirenz Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Efavirenz Tablets Company Ranking (2024-2026)
  6. 3.6 Global Efavirenz Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Efavirenz Tablets Company Product Type and Application
  8. 3.8 Global Efavirenz Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Efavirenz Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Efavirenz Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Efavirenz Tablets Market by Type
  1. 4.1 Efavirenz Tablets Type Introduction
  2. 4.1.1 200mg
  3. 4.1.2 50mg
  4. 4.1.3 600mg
  5. 4.2 Global Efavirenz Tablets Sales Volume by Type
  6. 4.2.1 Global Efavirenz Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Efavirenz Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Efavirenz Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Efavirenz Tablets Sales Value by Type
  10. 4.3.1 Global Efavirenz Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Efavirenz Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Efavirenz Tablets Sales Value Share by Type (2021-2032)
5 Efavirenz Tablets Market by Application
  1. 5.1 Efavirenz Tablets Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Child
  4. 5.2 Global Efavirenz Tablets Sales Volume by Application
  5. 5.2.1 Global Efavirenz Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Efavirenz Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Efavirenz Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Efavirenz Tablets Sales Value by Application
  9. 5.3.1 Global Efavirenz Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Efavirenz Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Efavirenz Tablets Sales Value Share by Application (2021-2032)
6 Efavirenz Tablets Regional Sales and Value Analysis
  1. 6.1 Global Efavirenz Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Efavirenz Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Efavirenz Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Efavirenz Tablets Sales by Region (2027-2032)
  5. 6.3 Global Efavirenz Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Efavirenz Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Efavirenz Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Efavirenz Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Efavirenz Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Efavirenz Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Efavirenz Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Efavirenz Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Efavirenz Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Efavirenz Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Efavirenz Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Efavirenz Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Efavirenz Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Efavirenz Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Efavirenz Tablets Sales Value Share by Country, 2025 VS 2032
7 Efavirenz Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Efavirenz Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Efavirenz Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Efavirenz Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Efavirenz Tablets Sales by Country (2027-2032)
  6. 7.4 Global Efavirenz Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Efavirenz Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Efavirenz Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Efavirenz Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Efavirenz Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Efavirenz Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Efavirenz Tablets Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Hetero
  14. 8.3.1 Hetero Company Information
  15. 8.3.2 Hetero Business Overview
  16. 8.3.3 Hetero Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hetero Efavirenz Tablets Product Portfolio
  18. 8.3.5 Hetero Recent Developments
  19. 8.4 Strides Pharma
  20. 8.4.1 Strides Pharma Company Information
  21. 8.4.2 Strides Pharma Business Overview
  22. 8.4.3 Strides Pharma Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Strides Pharma Efavirenz Tablets Product Portfolio
  24. 8.4.5 Strides Pharma Recent Developments
  25. 8.5 Anhui Biochem Bio-Pharmaceutical
  26. 8.5.1 Anhui Biochem Bio-Pharmaceutical Company Information
  27. 8.5.2 Anhui Biochem Bio-Pharmaceutical Business Overview
  28. 8.5.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
  30. 8.5.5 Anhui Biochem Bio-Pharmaceutical Recent Developments
  31. 8.6 Huahai Pharmaceutical
  32. 8.6.1 Huahai Pharmaceutical Company Information
  33. 8.6.2 Huahai Pharmaceutical Business Overview
  34. 8.6.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
  36. 8.6.5 Huahai Pharmaceutical Recent Developments
  37. 8.7 DESANO
  38. 8.7.1 DESANO Company Information
  39. 8.7.2 DESANO Business Overview
  40. 8.7.3 DESANO Efavirenz Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DESANO Efavirenz Tablets Product Portfolio
  42. 8.7.5 DESANO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Efavirenz Tablets Value Chain Analysis
  2. 9.1.1 Efavirenz Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Efavirenz Tablets Sales Mode & Process
  6. 9.2 Efavirenz Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Efavirenz Tablets Distributors
  9. 9.2.3 Efavirenz Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst